[8-K] Surgery Partners, Inc. Reports Material Event

Rhea-AI Filing Summary

Surgery Partners, Inc. announced the appointment of Justin Oppenheimer as Chief Operating Officer and National Group President, effective January 1, 2026. He joins from the Hospital for Special Surgery, where he spent a decade in leadership roles including Chief Strategy Officer and Chief Operating Officer.

Oppenheimer serves on the board of Urban Dove, a New York-based charter school management organization, and holds a B.A. in political economy from Princeton University and an MBA from Harvard Business School. The company referenced his employment agreement as Exhibit 10.1, dated October 27, 2025.

Insights

Healthcare services operations analyst

Leadership change focused on operations; strategic impact will emerge over time.

Surgery Partners named Justin Oppenheimer as COO and National Group President effective January 1, 2026. His prior roles at Hospital for Special Surgery included Chief Strategy Officer and COO, indicating experience in both growth planning and day-to-day execution.

The operational scope of the role suggests influence on efficiency, physician engagement, and service-line performance; however, outcomes depend on integration with existing platforms and market dynamics. The filing also notes an employment agreement as Exhibit 10.1, which typically outlines compensation and performance terms.

Watch for subsequent disclosures that describe specific operational priorities, any performance metrics tied to the agreement, and early execution markers in filings covering 2026.

0001638833FALSE00016388332025-11-122025-11-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2025

Surgery Partners, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware			001-37576			47-3620923
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)

340 Seven Springs Way, Suite 600

Brentwood, Tennessee 37027

(Address of Principal Executive Offices) (Zip Code)

(615) 234-5900

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

SGRY

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Justin Oppenheimer as Chief Operating Officer and National Group President

On November 12, 2025, Surgery Partners, Inc. (the “Company”) announced the appointment of Justin Oppenheimer to serve as Chief Operating Officer and National Group President of the Company, effective as of January 1, 2026.

Mr. Oppenheimer, age 41, joins Surgery Partners from the Hospital for Special Surgery (HSS), where he spent the past decade in a variety of leadership roles, including Chief Strategy Officer and Chief Operating Officer. He also serves on the Board of Directors for Urban Dove, a New York-based charter school management organization. He holds a B.A. degree in political economy from Princeton University, and an MBA from Harvard Business School.

Employment Agreement with Justin Oppenheimer

Mr. Oppenheimer's Employment Agreement is incorporated into this Item 5.02 by reference to Exhibit 10.1 of this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

10.1						Justin Oppenheimer Employment Agreement dated October 27, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SURGERY PARTNERS, INC.
By:			/s/ David T. Doherty David T. Doherty Executive Vice President, Chief Financial Officer

Date: November 12, 2025

FAQ

What leadership change did Surgery Partners (SGRY) announce?

The company appointed Justin Oppenheimer as Chief Operating Officer and National Group President, effective January 1, 2026.

What is Justin Oppenheimer’s background before joining SGRY?

He spent a decade at the Hospital for Special Surgery, serving as Chief Strategy Officer and Chief Operating Officer.

When does Justin Oppenheimer’s role at Surgery Partners begin?

His appointment is effective January 1, 2026.

Is there an employment agreement for the new COO at SGRY?

Yes. The employment agreement is referenced as Exhibit 10.1, dated October 27, 2025.

What are Justin Oppenheimer’s educational credentials?

He holds a B.A. in political economy from Princeton University and an MBA from Harvard Business School.

Does the filing mention any compensation details?

Specific compensation terms are not detailed in the excerpt; the agreement is incorporated by reference as Exhibit 10.1.